9-136676960-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_006412.4(AGPAT2):c.492+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000168 in 1,490,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006412.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- congenital generalized lipodystrophy type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal diabetes mellitusInheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AGPAT2 | NM_006412.4 | c.492+1G>A | splice_donor_variant, intron_variant | Intron 3 of 5 | ENST00000371696.7 | NP_006403.2 | ||
| AGPAT2 | NM_001012727.2 | c.492+1G>A | splice_donor_variant, intron_variant | Intron 3 of 4 | NP_001012745.1 | |||
| AGPAT2 | XM_047422636.1 | c.183+1G>A | splice_donor_variant, intron_variant | Intron 3 of 5 | XP_047278592.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGPAT2 | ENST00000371696.7 | c.492+1G>A | splice_donor_variant, intron_variant | Intron 3 of 5 | 1 | NM_006412.4 | ENSP00000360761.2 | |||
| AGPAT2 | ENST00000371694.7 | c.492+1G>A | splice_donor_variant, intron_variant | Intron 3 of 4 | 1 | ENSP00000360759.3 | ||||
| AGPAT2 | ENST00000472820.1 | n.420+1G>A | splice_donor_variant, intron_variant | Intron 1 of 3 | 1 | |||||
| AGPAT2 | ENST00000470861.1 | n.*67G>A | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 4AN: 149404Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000162 AC: 4AN: 247676 AF XY: 0.00000743 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 21AN: 1341282Hom.: 0 Cov.: 39 AF XY: 0.0000135 AC XY: 9AN XY: 666060 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000268 AC: 4AN: 149404Hom.: 0 Cov.: 32 AF XY: 0.0000274 AC XY: 2AN XY: 72934 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital generalized lipodystrophy type 1 Pathogenic:1Other:1
The variant is reported with the allele frequency of 0.001615% in gnomAD and is novel (not in any individuals) in 1000 Genomes. This variant has been reported to the ClinVar as Pathogenic. The variant affects an invariant splice nucleotide and is expected to cause loss of function. Downstream loss of function variants have been reported to be disease causing. The nucleotide change in AGPAT2 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 20301391, 32041611, 14557463)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at